Found: 4
Select item for more details and to access through your institution.
A novel 11β-hydroxysteroid dehydrogenase type1 inhibitor CNX-010-49 improves hyperglycemia, lipid profile and reduces body weight in diet induced obese C57B6/J mice with a potential to provide cardio protective benefits.
- Published in:
- BMC Pharmacology & Toxicology, 2014, v. 15, n. 1, p. 43, doi. 10.1186/2050-6511-15-43
- By:
- Publication type:
- Article
Treatment with CNX-011-67, a novel GPR40 agonist, delays onset and progression of diabetes and improves beta cell preservation and function in male ZDF rats.
- Published in:
- BMC Pharmacology & Toxicology, 2013, v. 14, n. 1, p. 1, doi. 10.1186/2050-6511-14-28
- By:
- Publication type:
- Article
Systematic assessment of social phobia in clinical practice.
- Published in:
- 1997
- By:
- Publication type:
- journal article
CNX-012-570, a direct AMPK activator provides strong glycemic and lipid control along with significant reduction in body weight; studies from both diet-induced obese mice and db/db mice models.
- Published in:
- Cardiovascular Diabetology, 2014, v. 13, n. 1, p. 3, doi. 10.1186/1475-2840-13-27
- By:
- Publication type:
- Article